<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Clinical and laboratory features of muscle enzyme deficiencies of glycogen metabolism</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Clinical and laboratory features of muscle enzyme deficiencies of glycogen metabolism</h1>
<div class="graphic"><div class="figure"><div class="ttl">Clinical and laboratory features of muscle enzyme deficiencies of glycogen metabolism</div><div class="cntnt"><table cellspacing="0"><colgroup span="5" width="20%"></colgroup> <tbody> <tr> <td class="subtitle1">Enzyme deficiency</td> <td class="subtitle1">CPK</td> <td class="subtitle1">Myoglobinuria</td> <td class="subtitle1">Muscle glycogen present/abnormal</td> <td class="subtitle1">Clinical features</td> </tr> <tr> <td>Muscle glycogen synthase deficiency (GSD 0b)</td> <td>Normal</td> <td>Not reported, present in an equine model</td> <td>Reduced glycogen content</td> <td> <p>Cardiomyopathy</p> Progressive weakness</td> </tr> <tr> <td>Lysosomal acid maltase deficiency (GSD II)</td> <td>Increased</td> <td>Absent</td> <td>Increased lysosomal glycogen</td> <td> <p>Hypotonia in infants</p> <p>Cardiomyopathy</p> Progressive weakness</td> </tr> <tr> <td>Glycogen debrancher deficiency (GSD III)</td> <td>Increased</td> <td>Absent</td> <td>Increased in &gt;90% of cases</td> <td> <p>Progressive weakness</p> Cardiomyopathy</td> </tr> <tr> <td>Glycogen branching enzyme deficiency (GSD IV)</td> <td>Normal</td> <td>Absent</td> <td>Polyglucosan</td> <td> <p>Highly variable age of onset</p> <p>Neurologic involvement</p> <p>Liver disease</p> Cardiomyopathy</td> </tr> <tr> <td>Muscle phosphorylase deficiency (GSD V)</td> <td>Increased</td> <td>Present</td> <td>Increased</td> <td> <p>Acute muscle pain</p> Progressive weakness</td> </tr> <tr> <td>Phosphofructokinase deficiency (GSD VII)</td> <td>Increased</td> <td>Present</td> <td> <p>Increased</p> Occasional polyglucosan</td> <td> <p>Exercise intolerance</p> Occasional gout</td> </tr> <tr> <td>Phosphoglycerate kinase deficiency</td> <td>Increased</td> <td>Present</td> <td>Increased</td> <td> <p>Exercise intolerance</p> <p>Variable neurologic involvement</p> Hemolysis</td> </tr> <tr> <td>Phosphorylase kinase deficiency (GSD IXd)</td> <td>Increased</td> <td>Absent</td> <td>Increased</td> <td>Exercise intolerance</td> </tr> <tr> <td>Phosphoglycerate mutase deficiency (GSD X)</td> <td>Increased</td> <td>Present</td> <td>Increased</td> <td> <p>Exercise intolerance</p> <p>Variable neurologic involvement</p> Hemolysis</td> </tr> <tr> <td>Lactate dehydrogenase A deficiency</td> <td>Increased</td> <td>Present</td> <td>Increased</td> <td>Exercise intolerance</td> </tr> <tr> <td>Aldolase A deficiency (GSD XII)</td> <td>Increased</td> <td>Present</td> <td>Increased</td> <td> <p>Myopathy</p> Variable hemolysis</td> </tr> <tr> <td>Beta-enolase deficiency (GSD XIII)</td> <td>Increased</td> <td>Present</td> <td>Increased or normal</td> <td>Exercise intolerance</td> </tr> <tr> <td>Phosphoglucomutase 1 deficiency (GSD XIV)</td> <td>Increased</td> <td>Present</td> <td>Increased or normal</td> <td> <p>Exercise intolerance</p> <p>Dilated cardiomyopathy</p> Protein glycosylation defects</td> </tr> <tr> <td>Glycogenin-1 deficiency (GSD XV)</td> <td>Normal</td> <td>Absent</td> <td>Polyglucosan/reduced normal glycogen</td> <td> <p>Cardiomyopathy</p> Progressive weakness</td> </tr> <tr> <td>RBCK1/ HOIL-1 deficiency</td> <td>Increased</td> <td>Absent</td> <td>Polyglucosan/reduced normal glycogen</td> <td> <p>Progressive weakness</p> <p>Cardiomyopathy</p> Increased infections</td> </tr> <tr> <td>Gamma subunit of AMP-activated protein kinase (PRKAG2) dysfunction</td> <td>Normal</td> <td>Absent</td> <td>Increased glycogen/variable polyglucosan</td> <td> <p>Cardiomyopathy</p> <p>Wolff-Parkinson-White syndrome</p> Atrioventricular conduction block</td> </tr> <tr> <td>LAMP 2 deficiency (formerly GSD IIb)</td> <td>Increased</td> <td>Absent</td> <td>Increased nonlysosomal glycogen</td> <td> <p>Cardiomyopathy</p> <p>Skeletal myopathy</p> <p>Neurologic involvement</p> Females also affected</td> </tr> </tbody></table></div><div class="graphic_footnotes">AMP: adenosine monophosphate; CPK: creatinine phosphokinase; GSD: glycogen storage disease; HOIL-1: heme-oxidized IRP2 ubiquitin ligase 1; LAMP 2: lysosome-associated membrane protein 2; RBCK1: RanBP-type and C3HC4-type zinc finger containing 1.</div><div class="graphic_reference">Courtesy of William J Craigen, MD, PhD.</div><div id="graphicVersion">Graphic 106089 Version 2.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
